Gilead Sciences (GILD) Free Cash Flow (2009 - 2025)
Gilead Sciences (GILD) reported Free Cash Flow of $3.43 billion for Q2 2026, up 376.8% from $720 million a year earlier and up 41.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Free Cash Flow (2009 - 2025) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gilead Sciences' Free Cash Flow came in at $12.94 billion, up 38.1% year-over-year; for FY2025, it was $9.46 billion, down 8.2% from FY2024.
- Free Cash Flow has a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- By year, Free Cash Flow came in at $10.31 billion in FY2024 (+38.9%), $7.42 billion in FY2023 (-11.1%), $8.34 billion in FY2022 (-22.8%) and $10.81 billion in FY2021 (+43.7%).
- Five-year quarterly Free Cash Flow spans a low of $720 million in Q2 2025 and a high of $4.17 billion in Q3 2024.
- Year over year, Free Cash Flow has now increased in each of the last three quarters, with growth averaging 70.9% over the last eight quarters.
- The high point for year-over-year Free Cash Flow in five years was Q2 2026 (growth of 376.8%); the low point was Q2 2024 (a decline of 45.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.43 billion (Q1 2026), $3.12 billion (Q4 2025) and $3.96 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.97 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.70 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.36 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 17.60 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 11.77 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 8.10 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 9.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 9.08 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.46 Bn |
| Dec 31, 2024 | 10.31 Bn |
| Dec 31, 2023 | 7.42 Bn |
| Dec 31, 2022 | 8.34 Bn |
| Dec 31, 2021 | 10.81 Bn |
| Dec 31, 2020 | 7.52 Bn |
| Dec 31, 2019 | 8.32 Bn |
| Dec 31, 2018 | 7.48 Bn |
| Dec 31, 2017 | 11.31 Bn |
| Dec 31, 2016 | 16.30 Bn |
| Dec 31, 2015 | 20.50 Bn |
| Dec 31, 2014 | 12.26 Bn |
| Dec 31, 2013 | 2.92 Bn |
| Dec 31, 2012 | 2.80 Bn |
| Dec 31, 2011 | 3.51 Bn |
| Dec 31, 2010 | 2.77 Bn |
| Dec 31, 2009 | 2.85 Bn |
API Access
Gilead Sciences Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow-annual", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();